Literature DB >> 18227367

The growing burden of diabetes mellitus in the US elderly population.

Frank A Sloan1, M Angelyn Bethel, David Ruiz, Alisa M Shea, Alisa H Shea, Mark N Feinglos.   

Abstract

BACKGROUND: The prevalence of diabetes mellitus is growing worldwide. Consequently, there has been increased emphasis on primary and secondary prevention of diabetes. To our knowledge, whether there have been actual improvements in outcomes in the last decade or so has not been documented in a nationally representative sample.
METHODS: We undertook this study to examine trends in rates of occurrence of diabetes and its complications in persons older than 65 years in the United States. National longitudinal analysis of Medicare claims and other Medicare program data for persons first diagnosed as having diabetes during 1994 (n=33 164), 1999 (n=31 722), or 2003 (n=40 058) were compared with 2 control groups of persons of approximately equal sample size who were not diagnosed as having diabetes, alternatively during 1994, 1999, or 2003 or for the entire period from 1994 to 1999 or from 1999 to 2004. The main outcome measures were death and complications of diabetes including cardiovascular, cerebrovascular, ophthalmic, renal, and lower extremity events.
RESULTS: The annual incidence of diabetes increased by 23% between 1994-1995 and 2003-2004, and prevalence increased by 62%. The mortality rate after diagnosis in persons having diagnosed diabetes decreased by 8.3% compared with that in the control groups. Complication rates among persons diagnosed as having diabetes generally increased or stayed the same compared with those in the control groups during 1994 to 2004 except for ophthalmic diseases associated with diabetes. Rates for some major complications were high; for example, the rate for congestive heart failure in the diabetes group during 1999 to 2004 was 475 per 1000 persons. In some cases, most notably renal events, including the most serious complications, there were increases in prevalence in both the diabetes and control groups.
CONCLUSION: The burden of financing and providing medical care for persons older than 65 in the United States having diagnosed diabetes is growing rapidly as a result of increased incidence and, especially, prevalence of diagnosed diabetes, decreased mortality, and overall lack of improvement in rates of complications in persons having diagnosed diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18227367     DOI: 10.1001/archinternmed.2007.35

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  60 in total

Review 1.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods.

Authors:  Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; Caroline Blackwell; Mark A Espeland; Michael S Lawlor; W Jack Rejeski; David C Goff
Journal:  Contemp Clin Trials       Date:  2009-09-13       Impact factor: 2.226

3.  Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates.

Authors:  Joshua Kramer; Elisabeth Ludlage Moeller; Audra Hachey; Keith G Mansfield; Lynn M Wachtman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

4.  A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetes.

Authors:  Sandra B Dunbar; Brittany Butts; Carolyn M Reilly; Rebecca A Gary; Melinda K Higgins; Erin P Ferranti; Steven D Culler; Javed Butler
Journal:  Nurs Outlook       Date:  2013-10-02       Impact factor: 3.250

5.  The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial.

Authors:  Jeffrey A Katula; Mara Z Vitolins; Timothy M Morgan; Michael S Lawlor; Caroline S Blackwell; Scott P Isom; Carolyn F Pedley; David C Goff
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

6.  Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.

Authors:  Vicki Fung; Carol M Mangione; Jie Huang; Norman Turk; Elaine S Quiter; Julie A Schmittdiel; John Hsu
Journal:  Health Serv Res       Date:  2009-12-30       Impact factor: 3.402

7.  Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.

Authors:  Michael R Sargen; Ole Hoffstad; David J Margolis
Journal:  J Diabetes Complications       Date:  2012-10-11       Impact factor: 2.852

8.  Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.

Authors:  Massimiliano Balbi; Valter Donadon; Michela Ghersetti; Silvia Grazioli; Giovanni Della Valentina; Rita Gardenal; Maria Dal Mas; Pietro Casarin; Giorgio Zanette; Cesare Miranda; Paolo Cimarosti
Journal:  Int J Environ Res Public Health       Date:  2010-03-29       Impact factor: 3.390

9.  Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.

Authors:  Powen Tu; Shalender Bhasin; Paul W Hruz; Karen L Herbst; Lawrence W Castellani; Ning Hua; James A Hamilton; Wen Guo
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

Review 10.  Diabetes surgery: a new approach to an old disease.

Authors:  Francesco Rubino; Tracy-Ann Moo; Daniel J Rosen; Greg F Dakin; Alfons Pomp
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.